Last update:
Medications news
Medications
FDA approves injectable Ocrevus Zunovo for relapsing, progressive multiple sclerosis
The U.S. Food and Drug Administration has approved Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) as the first and only twice-a-year, 10-minute subcutaneous injection for people with relapsing and progressive multiple ...
1 hour ago
0
0
Medications
Synthetic compound shows promise against drug-sensitive, drug-resistant strains of human malaria parasites
In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent, prevalent, and deadly human malaria parasite. For decades, the parasite's resistance to all antimalarial drugs ...
4 hours ago
0
6
FDA approves Bimzelx for three new indications
The U.S. Food and Drug Administration has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with active psoriatic arthritis (PsA), adults with active nonradiographic axial spondyloarthritis (nr-axSpA) with objective ...
1 hour ago
0
0
EU watchdog puts sickle cell disease drug on ice
The EU's drug watchdog Thursday called for the suspension of approval for Pfizer's medicine to treat sickle cell disease, saying doctors should stop using the drug.
4 hours ago
0
1
Newly identified 'compound B' holds promise as better immune booster against cancer, chronic diseases
A team of University of Alberta researchers has created a molecular compound that activates the immune system and shows promise for becoming an effective and versatile treatment for cancer and chronic infections.
5 hours ago
0
0
An oral weight loss pill has just passed early trials with promising results—here's how it works
The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been shown to lead to significant weight loss in users—as much as 15% or more of their body weight ...
6 hours ago
0
0
Risk of buprenorphine triggering sudden opioid withdrawal is low, researchers find
Buprenorphine, an evidence-based treatment for opioid use disorder, is currently underprescribed because of concerns that it can cause "precipitated withdrawal," in which the first dose causes sudden, intense pain and anxiety ...
18 hours ago
0
0
Popular diabetes and weight-loss drug associated with lower opioid overdose risk
Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the National Center for Drug Abuse Statistics.
Sep 25, 2024
0
13
Higher doses of buprenorphine may improve treatment outcomes for people with opioid use disorder
Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent emergency department visits or use of inpatient services related ...
Sep 25, 2024
0
0
Study finds certain multiple sclerosis therapies may not slow disability progression
In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not receiving treatment. ...
Sep 25, 2024
0
0
US Congress calls on Novo Nordisk to lower drug prices
The boss of the Danish pharmaceutical giant behind the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy promised Tuesday to examine lowering their prices in the United States, after coming under pressure from ...
Sep 25, 2024
0
0
Researchers publish critical examination of new brain tumor drug
Two researchers from the Icahn School of Medicine at Mount Sinai recently published their critical evaluation of a new brain tumor medicine in the journal Nature Reviews Clinical Oncology.
Sep 24, 2024
0
1
Google trends reveals surge in ADHD medication searches during COVID-19 pandemic
In a study published in Brain Medicine, UCI researchers have uncovered a striking correlation between internet searches for ADHD medications and actual prescription rates during the COVID-19 pandemic. This finding opens up ...
Sep 24, 2024
0
0
New guideline could enhance treatment access for opioid use disorder in community pharmacies
Pharmacists now have more guidance for combating the opioid crisis and providing treatment to patients, thanks to new national guidelines developed at the University of Houston College of Pharmacy. The Pharmacy Access to ...
Sep 24, 2024
0
1
High response incidence seen for axatilimab in recurrent, refractory graft-versus-host disease
For patients with recurrent or refractory graft-versus-host disease (GVHD), the colony-stimulating factor 1 receptor (CSF1R)-blocking antibody axatilimab results in a high incidence of overall response, according to a study ...
Sep 23, 2024
0
0
Study shows psilocybin gives comparable long-term antidepressant effects to standard antidepressants
A direct comparison between the experimental psychedelic drug psilocybin and a standard SSRI antidepressant shows similar improvement of depressive symptoms, but that psilocybin offers additional longer-term benefits.
Sep 21, 2024
0
94
New migraine drugs no better than cheap painkillers: big study
New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and even performed worse than an older range of treatments called triptans, said a massive global analysis ...
Sep 21, 2024
0
63
Revolution or mirage? Controversy surrounds new Alzheimer's drugs
Two new drugs, the first capable of slowing down the debilitating progression of Alzheimer's disease, have become embroiled in one of the biggest medical controversies in recent years.
Sep 20, 2024
1
23
The winding, fitful path to diabetes drug Ozempic
Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic—so what was that journey like for the scientists involved?
Sep 19, 2024
0
12
Study reveals secrets behind Lycium barbarum's cold and heat resistance efficacy
Lycium barbarum is a traditional and valuable medicinal herb in China. It has the effects of "strengthening muscles and bones with prolonged use, promoting longevity, and resisting cold and heat," according to "Ben Cao Gang ...
Sep 19, 2024
0
0
FDA approves Ebglyss for moderate-to-severe atopic dermatitis
The U.S. Food and Drug Administration has approved Eli Lilly's Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 years and older with moderate-to-severe atopic dermatitis.
Sep 19, 2024
0
1
Weight loss drugs could help fight fatty liver disease
In the fight against fatty liver disease, researchers are looking for any and all possible solutions. But to combat the disease, which is also known as metabolic dysfunction-associated steatotic liver disease, or MASLD, scientists ...
Sep 18, 2024
0
33
The most effective migraine drugs should be promoted globally and guidelines updated accordingly, say researchers
Some triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the latest evidence published in The BMJ.
Sep 18, 2024
0
4
Severe side effects of the most effective schizophrenia medication identified
About one-third of patients with schizophrenia do not respond to conventional medications, leaving them with one effective treatment option: clozapine. Clozapine's most serious side effect, a life-threatening drop in white ...
Sep 18, 2024
0
39
FDA expands use of breast cancer drug Kisqali
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded approval of the treatment, drug maker Novartis announced ...
Sep 18, 2024
0
1
